CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-19 | FINGER ALISON CECILY Director | Grant or award · Stock Option (right to buy) | +16,279 | 16,279 | ||
| 2025-02-19 | Tade Brad L. CFO and Treasurer | Grant or award | +62,227 | 261,660 | ||
| 2025-02-19 | Tade Brad L. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +93,023 | 93,023 | ||
| 2025-02-19 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Grant or award | +77,784 | 524,016 | ||
| 2025-02-19 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Grant or award · Stock Option (right to buy) | +116,279 | 116,279 | ||
| 2025-02-19 | Grossman Adam S President and CEO | Grant or award | +252,022 | 2,226,686 | ||
| 2025-02-19 | Grossman Adam S President and CEO | Grant or award · Stock Option (right to buy) | +376,744 | 376,744 | ||
| 2025-01-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Option exercise | +5,000 | $10.80 | $54K | 449,587 |
| 2025-01-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −3,355 | $16.10 | $54K | 446,232 |
| 2025-01-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Option exercise · Employee Stock Option (right to buy) | −5,000 | 0 | ||
| 2024-12-31 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −1,854 | $17.15 | $32K | 444,587 |
| 2024-12-31 | Grossman Adam S President and CEO | Shares withheld for taxes | −14,343 | $17.15 | $246K | 1,974,664 |
| 2024-12-30 | Salas Eduardo Rene Director | Grant or award · Stock Option (right to buy) | +20,011 | 20,011 | ||
| 2024-11-27 | ELMS STEVE Director | Option exercise | +9,000 | $10.80 | $97K | 2,124,671 |
| 2024-11-27 | ELMS STEVE Director | Option exercise · Stock Option (Right to Buy) | −9,000 | 0 | ||
| 2024-11-22 | Tade Brad L. CFO and Treasurer | Sale | −15,000 | $21.15 | $317K | 199,433 |
| 2024-11-22 | Grossman Adam S President and CEO | Sale | −48,967 | $21.10 | $1.0M | 1,989,007 |
| 2024-09-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −2,647 | $19.99 | $53K | 446,441 |
| 2024-09-30 | Grossman Adam S President and CEO | Shares withheld for taxes | −21,752 | $19.99 | $435K | 2,037,974 |
| 2024-09-09 | Guiheen Lawrence P. Director | Option exercise | +9,000 | $10.80 | $97K | 162,941 |
Page 9 of 31 · 618 trades